First Turn Management »

Rhythm Pharmaceuticals shares owned by First Turn Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $16M 146k 107.04

More positions owned by First Turn Management

Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Insmed Com Par $.01 (INSM)
Bridgebio Pharma (BBIO)
Mirum Pharmaceuticals (MIRM)
Axsome Therapeutics (AXSM)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Terns Pharmaceuticals (TERN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
United Therapeutics Corporation (UTHR)
Vera Therapeutics Cl A (VERA)
Cogent Biosciences (COGT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for First Turn Management

Top funds holding Rhythm Pharmaceuticals

Perceptive Advisors
BlackRock
Vanguard Group
RA Capital Management
Baker Bros. Advisors
PRIMECAP Management Company
NEA Management Company
State Street Corporation
FMR
Goldman Sachs Group
Federated Investors
Driehaus Capital Management
Geode Capital Management
Westfield Capital Management Company
Jpmorgan Chase & Co

View all funds holding Rhythm Pharmaceuticals